鄰近類別 圖書 [5/7] 會議論文/會議摘要 [25/32] 類別統計 近3年內發表的文件:15(9.49%) 含全文筆數:158(100.00%) 文件下載次數統計 下載大於0次:158(100.00%) 下載大於100次:150(94.94%) 檔案下載總次數:79818(83.75%) 最後更新時間: 2024-12-01 01:03 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Registry of genetic alterations of ... A statistical method for protocol m... Immune killer cells treatment for p... Survival of advanced/recurrent gast... The clinical characteristics and ma... A phase 1 study of biweekly nab-pac... Polygenic risk score, environmental... Genome-wide association study of lu... Bayesian hierarchical models for ad... Recalibrating risk prediction model...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 158. (共7頁) 1 2 3 4 5 6 7 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2024-09-30	Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521	JCO Global Oncology. 2024 Sep 30;10:Article number e2400125.
2024-08-28	A statistical method for protocol modifications with heterogeneous population variances	Statistics in Biopharmaceutical Research. 2024 Aug 28;Article in Press.
2024-08-21	Immune killer cells treatment for previously treated stage IV NSCLC patients	Scientific Reports. 2024 Aug 21;14:Article number 19374.
2024-07-11	Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study	BMC Cancer. 2024 Jul 11;24:Article number 828.
2024-06-24	The clinical characteristics and manifestation of anxious depression among patients with major depressive disorders-results from a Taiwan multicenter study	Psychiatry Investigation. 2024 Jun 24;21(6):561-572.
2023-11-13	Polygenic risk score, environmental tobacco smoke, and risk of lung adenocarcinoma in never-smoking women in Taiwan	JAMA Network Open. 2023 Nov 13;6(11):Article number e2339254.
2023-05-26	Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population	Nature Communications. 2023 May 26;14:Article number 3043.
2023-05	Bayesian hierarchical models for adaptive basket trial designs	Pharmaceutical Statistics. 2023 May-Jun;22(3):531-546.
2022-12	Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan	Cancer Epidemiology, Biomarkers and Prevention. 2022 Dec 5;31(12):2208-2218.
2022-10	Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study	Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
2022-06-02	Trial Designs for integrating novel therapeutics into the management of intermediate-stage hepatocellular carcinoma	Journal of Hepatocellular Carcinoma. 2022 Jun 2;9:517-536.
2022-06	Three-stage pooled plasma hepatitis C virus RNA testing for the identification of acute HCV infections in at-risk populations	Microbiology Spectrum. 2022 Jun 29;10(3):Article number e0243721.
2022-01	Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances	Statistics in Medicine. 2022 Jan 15;41(1):87-107.
2022-01	Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients	Clinical and Translational Radiation Oncology. 2022 Jan;32:59-68.
2021-11-12	The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience	Frontiers in Oncology. 2021 Nov 12;11:Article number 741096.
2021-09-27	Comment on"Biostatistical considerations when using RWD and RWE in clinical studies for regulatory purposes: A landscape assessment": Is real-world evidence real?	Statistics in Biopharmaceutical Research. 2021 Sep 27;15(1):18-19.
2021-05	High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial	Radiotherapy and Oncology. 2021 May;158:146-154.
2021-02-05	Tolerance interval testing for assessing accuracy and precision simultaneously	PLoS ONE. 2021 Feb 5;16(2):Article number e0246642.
2021-02	On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes	Contemporary Clinical Trials. 20201 Feb;101:Article number 106244.
2021-01	Use of a two-sided tolerance interval in the design and evaluation of biosimilarity in clinical studies	Pharmaceutical Statistics. 2021 Jan;20(1):175-184.
2020-12-29	Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia	Environment International. 2020 Dec 29;147:Article number 105975.
2020-12-02	A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)	PLoS ONE. 2020 Dec 2;15(12):Article number e0242763.
2020-11	Use of tolerance intervals for assessing biosimilarity	Statistics in Medicine. 2020 Nov;39(26):3806-3822.
2020-10	Operational experiences in China and statistical issues on the conduct of clinical trials during the COVID-19 pandemic	Statistics in Biopharmaceutical Research. 2020 Oct;12(4):438-442.

顯示項目1-25 / 158. (共7頁) 1 2 3 4 5 6 7 > >> 每頁顯示[10|25|50]項目